Not checked for notices yet.

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

Ignacio Melero, Alvaro Teijeira, Iñaki Etxeberría and 1 more

ESMO Open · 2019

doi:10.1136/esmoopen-2020-000733

Cited by papers we hold 3

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors · 2022
No notice
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response · 2022
No notice
Signal pathways of melanoma and targeted therapy · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.